22nd Century Group is an agricultural biotechnology company that focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science. They develop low nicotine content tobacco and cigarette products and collaborate with Keygene N.V. to develop hemp/cannabis plants for medical, therapeutic, and agricultural uses. The company was founded in 1998 and is headquartered in Buffalo, New York.